NIPT Ravgen NIPT Patents Withstand Illumina Challenge The US Patent Trial and Appeal Board delivered a pair of rulings stating that Illumina failed to show Ravgen's innovations should be considered unpatentable. Myriad Genetics Highlights 2023 Product Launches for Women's Health, Oncology Businesses Premium The company is planning to launch a 4-in-1 prenatal screening test, a liquid biopsy test, and a minimal residual disease assay in the coming year. Digital PCR Startup Enumerix's Ultra-dPCR Method Massively Expands Droplet Number Premium The Ultra-dPCR method purports to create approximately 30 million droplets using a low-cost consumable and standard lab instruments. ACMG Strongly Recommends NIPS for Common Trisomies for All Pregnancies The new guidelines, based on a recent evidence review, also recommend offering NIPS for detecting fetal sex chromosome aneuploidies for singleton pregnancies. BillionToOne Secures $83.5M in Private Funding, Loan Facility; Shows Clinical Performance of NIPT Premium In a recent study, pregnancy outcomes correlated with the Unity test's fetal risk estimates for recessive conditions, and the company is now conducting further validation studies. Dec 14, 2022 Ravgen's NIPT Patents Found Valid in Administrative Challenge Dec 6, 2022 Cowen Upgrades PerkinElmer Stock to Outperform Nov 28, 2022 Juno Diagnostics Lowers Barriers to Noninvasive Prenatal Testing With At-Home Sample Collection Premium Nov 28, 2022 ARCEDI Biotech Developing Cystic Fibrosis, Cancer Tests; Plans to Expand NIPT Offering Premium Nov 9, 2022 Dante Genomics, Al Farabi Medical Laboratories Partner on NGS-Based Testing in Saudi Arabia Nov 9, 2022 Natera Raises Guidance on Test Volume Growth, Notes Reimbursement Opportunities Premium Oct 20, 2022 Meet Ravgen, the Little-Known Company Rattling NIPTs Biggest Players in Court Premium Oct 11, 2022 Quest Diagnostics, Ravgen Settle Patent Infringement Suit Sep 27, 2022 Ravgen Wins $273M Award in Patent Infringement Suit Against Labcorp Aug 16, 2022 Sema4 Cuts 13 Percent of Workforce, Exits Somatic Tumor Testing as Founder Schadt Departs Premium Aug 2, 2022 LGC Clinical Diagnostics, Stanford University Extend Collaboration for NIPT Reference Materials Jul 14, 2022 Genetic Counseling Likely to Become More 'Complicated' in Wake of Roe Repeal Premium Jun 2, 2022 Genome-Wide Noninvasive Prenatal Genetic Testing Uncovers Additional Findings Beyond Common Trisomies May 24, 2022 ACMG Review Finds NIPS Accurately Detects Common Trisomies in General-Risk Pregnancies May 5, 2022 Natera Q1 Revenues Rise 28 Percent on Increased Product Revenues Apr 25, 2022 Yourgene Health, Ambry Genetics Team on Genomic Services Under Extended Strategic Partnership Apr 20, 2022 FDA Cautions of False Results From Prenatal Genetic Tests Mar 30, 2022 BillionToOne Raises $125M in Series C Funding Round Mar 9, 2022 Natera Refutes Claims in Short Seller Report After Stock Plummets Feb 25, 2022 Natera Hit With Multiple Class Action Suits Over 'Unreliable' NIPT Results Load More Breaking News New Products Posted to GenomeWeb: Qiagen, Thermo Fisher, Bionano Genomics, BillionToOne, More People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More Genomic Approaches Boost Rare Disease Diagnoses in Middle Eastern Patient Population GeneDx to Raise $150M in Public and Direct Stock Offerings In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More The Scan Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups. Genome-Wide Analysis Sheds Light on Genetics of ADHD A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder. MicroRNA Cotargeting Linked to Lupus A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus. Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.